Abstract:Ischemic retinopathies including diabetic retinopathy are major causes of vision loss. Inner blood-retinal barrier (BRB) breakdown with retinal vascular hyperpermeability results in macular edema. Although dysfunction of the neurovascular unit including neurons, glia, and vascular cells is now understood to underlie this process, there is a need for fuller elucidation of the underlying events in BRB dysfunction in ischemic disease, including a systematic analysis of myeloid cells and exploration of cellular cross-talk. We used an approach for microglia depletion with the CSF-1R inhibitor PLX5622 (PLX) in the retinal ischemia-reperfusion (IR) model. Under non-IR conditions, PLX treatment successfully depleted microglia in the retina. PLX suppressed the microglial activation response following IR as well as infiltration of monocyte-derived macrophages. This occurred in association with reduction of retinal expression of chemokines including CCL2 and the inflammatory adhesion molecule ICAM-1 . In addition, there was a marked suppression of retinal neuroinflammation with reduction in expression of IL-1b , IL-6 , Ptgs2 , TNF-a , and Angpt2 , a protein that regulates BRB permeability. PLX treatment significantly suppressed inner BRB breakdown following IR, without an appreciable effect on neuronal dysfunction. A translatomic analysis of Müller glial-specific gene expression in vivo using the Ribotag approach demonstrated a strong suppression of Müller cell expression of multiple pro-inflammatory genes following PLX treatment. Co-culture studies of Müller cells and microglia demonstrated that activated microglia directly upregulates Müller cell-expression of these inflammatory genes, indicating Müller cells as a downstream effector of myeloid cells in retinal IR. Co-culture studies of these two cell types with endothelial cells demonstrated the ability of both activated microglia and Müller cells to compromise EC barrier function. Interestingly, quiescent Müller cells enhanced EC barrier function in this co-culture system. Together this demonstrates a pivotal role for myeloid cells in inner BRB breakdown in the setting of ischemia-associated disease and indicates that myeloid cells play a major role in iBRB dysregulation, through direct and indirect effects, while Müller glia participate in amplifying the neuroinflammatory effect of myeloid cells.

New Insights on the Role of Micrornas in Retinal Müller Glial Cell Function

New insight of Muller glial cells functions: focus on microRNAs-dependent manner

Microglia in retinal diseases: From pathogenesis towards therapeutic strategies

Retinal Micrornas and Their Roles in Retinal Diseases

Epigenetic mechanisms of Müller glial reprogramming mediating retinal regeneration

Cellular Signaling in Muller Glia: Progenitor Cells for Regenerative and Neuroprotective Responses in Pharmacological Models of Retinal Degeneration

The roles of microglia in neural remodeling during retinal degeneration

Advances in the study of Müller glia reprogramming in mammals

[Expression and Function of Microrna in the Eye].

Retinal microglia: Functions and diseases

Microglia in the Retina: Roles in Development, Maturity, and Disease

MicroRNA profile of extracellular vesicles released by Müller glial cells

Suppression of inner blood-retinal barrier breakdown and pathogenic Müller glia activation in ischemia retinopathy by myeloid cell depletion

Microglia in retinal angiogenesis and diabetic retinopathy

Myeloid cells in retinal and brain degeneration

Research advances on expression and significance of microRNAs in eyes

Repopulated retinal microglia promote Müller glia reprogramming and preserve visual function in retinal degenerative mice

MicroRNAs of microglia: Wrestling with central nervous system disease

Single-cell Transcriptome Analyses Reveal Microglia Types Associated with Proliferative Retinopathy

Investigating Müller glia reprogramming in mice: a retrospective of the last decade, and a look to the future

Expression and function of microRNAs in retinopathy